期刊
PHARMACEUTICALS
卷 16, 期 10, 页码 -出版社
MDPI
DOI: 10.3390/ph16101480
关键词
G protein-coupled receptor 44 (GPR44); F-18-labeling; chemoattractant receptor-homologous molecule expressed on T-helper type 2 cells (CRTH2); prostaglandin D-2 receptor 2 (DP2); prostaglandin D-2 (PGD(2)); inflammation; automatic model; diabetes; cancer; human islets
GPR44 has been found to play a significant role in inflammation-related diseases, but its precise mechanism is still unclear. This study successfully developed [F-18]TM-30089 as a radiotracer for GPR44 and demonstrated its promising targeting ability. This may contribute to the understanding of GPR44's mechanism and monitoring of therapeutic progress.
Recently, a G-protein coupled receptor 44 (GPR44) was discovered to play a significant role in the process of inflammation-related diseases, including cancer and diabetes. However, the precise role of GPR44 has yet to be fully elucidated. Currently, there is a strong and urgent need for the development of GPR44 radiotracers as a non-invasive methodology to explore the exact mechanism of GPR44 on inflammation-related diseases and monitor the progress of therapy. TM-30089 is a potent GPR44 antagonist that exhibits a high specificity and selectivity for GPR44. Its structure contains a fluorine nuclide, which could potentially be replaced with F-18. In the present study, we successfully took a highly effective synthesis strategy that pretreated the unprotected carboxylic acid group of the precursor and developed a feasible one-step automatic radiosynthesis strategy for [F-18]TM-30089 with a high radiochemical purity and a good radiochemical yield. We further evaluated this radiotracer using mice models implanted with 1.1 B4 cell lines (GPR44-enriched cell lines) and human islets (high GPR44 expression), respectively. The results revealed the persistent and specific uptake of [F-18]TM-30089 in GPR44 region, indicating that [F-18]TM-30089 is a promising candidate for targeting GPR44. Further evaluation is ongoing
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据